NINLARO
Active substance: ixazomib
CAPSULE · IXAZOMIB CITRATE 4 mg/1
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- IXAZOMIB CITRATE · 4 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-63c5-7ebf-b53d-073426c6fc91,01a12096-ae47-7c46-9696-7808069fc206,01a1209d-c050-7a54-a328-64732efa3f9b;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63020-400
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63020-400 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63020-400 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63020-400 · Verified 2026-10-09 · open in source